Natco Pharma Ltd Quarterly Results

Gross Sales

1,363

1,328.9

1,221

474.8

1,371.1

Excise Duty

0

0

0

0

0

Net Sales

1,363

1,328.9

1,221

474.8

1,371.1

Other Operating Income

0

0

0

0

0

Other Income

100

61.7

66.3

176.3

63.8

Total Income

1,463

1,390.6

1,287.3

651.1

1,434.9

Total Expenditure

783.8

757.9

672.9

436

566.8

PBIDT

679.2

632.7

614.4

215.1

868.1

Interest

13.1

3.2

10.2

4.4

4.1

PBDT

666.1

629.5

604.2

210.7

864

Depreciation

52.4

57.6

98.3

47

45.8

Minority Interest Before NP

0

0

0

0

0

Tax

140.4

115.7

106.4

33.5

154.1

Deferred Tax

-44.6

-24.1

-6.5

-2.2

-12.4

Reported Profit After Tax

517.9

480.3

406

132.4

676.5

Minority Interest After NP

-0.5

-0.4

-0.6

-0.6

-0.8

Net Profit after Minority Interest

518.4

480.7

406.6

133

677.3

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

518.4

480.7

406.6

133

677.3

EPS (Unit Curr.)

28.94

26.84

22.7

7.43

37.81

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

75

100

0

75

75

Equity

35.8

35.8

35.8

35.8

35.8

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

49.83

47.61

50.31

45.3

63.31

PBDTM(%)

48.87

47.37

49.48

44.37

63.01

PATM(%)

37.99

36.14

33.25

27.88

49.33